Acceleron Pharma
Patents, Design & Utilities
Last updated:
List of all Acceleron Pharma patents 134 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS Filling date: 8 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Compositions and methods for treating pulmonary hypertension Filling date: 8 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Methods and compositions for reducing serum lipids Filling date: 8 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: ALK7 binding proteins and uses thereof Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Grant | Utility: ALK7:actriib heteromultimers and uses thereof Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Transforming growth factor beta receptor type II fusion polypeptides Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS Filling date: 8 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Grant | Utility: Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides Filling date: 8 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Methods of increasing muscle mass by administration of activin type 2 receptor antibodies Filling date: 8 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Method for treating a muscle-related disorder with follistatin-related fusion proteins Filling date: 8 Sep 2025 Issue date: 11 May 2021 |
Application | Utility: ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Endoglin polypeptides and uses thereof Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: SINGLE-ARM CO-RECEPTOR FUSION PROTEINS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Compositions and methods for treating pulmonary hypertension Filling date: 8 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Methods for screening compounds for increasing thermogenic adipocytes Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Methods of increasing sarcolemmal utrophin Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Methods and compositions for treatment of disorders with follistatin polypeptides Filling date: 8 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Compositions and methods for treating pulmonary hypertension Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: ALK4.ActRIIB heteromultimers Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 |
Application | Utility: METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR DOSING AN ACTIVIN-ACTRIIA ANTAGONIST AND MONITORING OF TREATED PATIENTS Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Grant | Utility: TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Grant | Utility: Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: BMPRII POLYPEPTIDES AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS USING GDF15 POLYPEPTIDES FOR INCREASING RED BLOOD CELLS Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ALK7 BINDING PROTEINS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Methods and compositions for increasing red blood cells Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Methods for treating myelodysplastic syndromes and sideroblastic anemias Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: TGFBETA AND ACTRII ANTAGONISTS FOR USE IN INCREASING IMMUNE ACTIVITY Filling date: 8 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: Methods for treatment of charcot-marie-tooth disease with follistatin polypeptides Filling date: 8 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS Filling date: 8 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: ALK4:ActRIIB heteromultimers and uses thereof Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Compositions and methods for treating pulmonary hypertension Filling date: 8 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: ISOLATED GDF TRAP POLYPEPTIDE Filling date: 8 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: Compositions and methods for treating pulmonary hypertension Filling date: 8 Sep 2025 Issue date: 30 Jun 2020 |
Showing 50 to 100 of 134 patents.